Financials
- Market Capitalization 1.78 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-63.19
売上高対価格比率
15.2
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2069 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD | ||
| 2084 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.73 USD | -1.09% | -0.55% | +20.21% | -7.22% | 1.78 B USD | ||
| 2096 | FTRE Fortrea Holdings Inc. - Common Stock | 18.37 USD | -2.34% | +0.22% | -4.52% | +90.56% | 1.75 B USD | ||
| 2108 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.29 USD | -1.28% | -2.23% | +1.47% | +16.91% | 1.72 B USD |